Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.

× No keyword cloud information.

17 in total

Review 1. Endovascular ablation of atrial fibrillation.

Authors: Vivek Malladi; Payam S Naeini; Mehdi Razavi; Charles D Collard; James M Anton; Daniel A Tolpin
Journal: Anesthesiology Date: 2014-06 Impact factor: 7.892

2. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

Authors: Vivek Y Reddy; David Holmes; Shephal K Doshi; Petr Neuzil; Saibal Kar
Journal: Circulation Date: 2011-01-17 Impact factor: 29.690

3. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Authors: Vivek Y Reddy; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Jonathan L Halperin; David Holmes
Journal: Circulation Date: 2013-01-16 Impact factor: 29.690

4. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.

Authors: Krzysztof Bartus; Frederick T Han; Jacek Bednarek; Jacek Myc; Boguslaw Kapelak; Jerzy Sadowski; Jacek Lelakowski; Stanislaw Bartus; Steven J Yakubov; Randall J Lee
Journal: J Am Coll Cardiol Date: 2012-10-10 Impact factor: 24.094

5. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors: David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal: J Am Coll Cardiol Date: 2014-07-08 Impact factor: 24.094

6. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.

Authors: Ali Massumi; Mihail Gabriel Chelu; Alireza Nazeri; Stephen Allen May; Hamid Afshar-Kharaghan; Mohammad Saeed; Mehdi Razavi; Abdi Rasekh
Journal: Am J Cardiol Date: 2013-01-09 Impact factor: 2.778

7. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors: David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal: Lancet Date: 2009-08-15 Impact factor: 79.321

8. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices.

Authors: Muhammad R Afzal; Arun Kanmanthareddy; Matthew Earnest; Madhu Reddy; Donita Atkins; Sudharani Bommana; Krystof Bartus; Abdi Rasekh; Fred Han; Nitish Badhwar; Jie Cheng; Luigi Dibiase; Christopher R Ellis; Buddhadeb Dawn; Andrea Natale; Randall J Lee; Dhanunjaya Lakkireddy
Journal: Heart Rhythm Date: 2014-10-02 Impact factor: 6.343

Where We Stand on Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.

Review 1. Endovascular ablation of atrial fibrillation.

2. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.

3. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

4. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.

5. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

6. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.

7. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

8. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices.

9. Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update.

Review 10. Left atrial appendage closure devices.

Review 1. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.

2. Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation.

Review 3. Left Atrial Appendage Closure and Pulmonary Vein Isolation.